製薬用錠剤コーティングの世界市場の評価：タイプ別、ポリマータイプ別、機能性別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界の製薬用錠剤コーティングの市場規模は、2023年の10億1,000万米ドルから2031年に16億2,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで6.1％の成長が見込まれます。市場の成長は、製薬部門の拡大と研究開発活動の活発化によって支えられています。

製薬部門の急成長が世界の製薬用錠剤コーティングの市場規模を押し上げています。この成長は、世界中のさまざまな地域におけるさまざまな疾患や障害の有病率の増加や人口の急激な増加に起因しています。例えば、Invest Indiaは、同国の製薬産業が2030年までに1,300億米ドルに達すると予測しています。さらに、医薬品製造の品質が重視されるようになり、ジェネリック医薬品の採用が増加しているため、市場に有利な成長機会がもたらされ、製薬用錠剤コーティングの需要が高まっています。さまざまな賦形剤と医薬品に関する規制の厳格化が、市場拡大をさらに後押ししています。

市場の主要企業が、実行可能な製薬用錠剤コーティングのコスト効率とタイムリーな提供を支援する機器を製造するための投資を増やしていることが、市場成長をさらに促進しています。さらに、さまざまな治療へのアクセス性を高め、患者の生活の質を向上させる費用対効果の高さによってバイオシミラーの人気が高まっていることも、市場の拡大を後押ししています。例えば、Amgen Biosimilarsの2022 Biosimilar Trends Reportでは、過去3年間に上市したバイオシミラーの治療領域における平均シェアは75％と推定されています。バイオシミラーは、基準となる生物学的製剤の有効成分を模倣するものであり、基準となる生物学的製剤と類似した特性の存在を確認するために広範な分析が行われます。このように、バイオシミラー部門は大幅な成長を示しており、その結果、製薬用錠剤コーティングの需要が高まり、市場の拡大にプラスの影響を与えています。

ジェネリック医薬品の普及が市場需要を押し上げる

ジェネリック医薬品の人気の高まりは、その費用対効果の高さと、これらの医薬品が従わなければならない厳格な規制基準に対する意識の高まりによるものと考えられます。FDAから認可を受けるためには、ジェネリック医薬品は先発医薬品と生物学的に同等でなければなりません。このことは、ジェネリック医薬品メーカーは有効成分を先発品から20％変更することを認められているとはいえ、2つの医薬品が化学的に同じであることを保証します。FDAの許容範囲は最大20％ですが、通常は4％以下のばらつきしかありません。ジェネリック医薬品が従うこのような厳格な規制基準に対する一般消費者の意識の高まりにより、ジェネリック医薬品への信頼が高まっています。例えば、Association for Accessible Medicinesは、米国における処方箋の約90％がジェネリック医薬品であると推定しています。こうして製薬用錠剤コーティングの需要が高まり、市場の成長を支えています。

製薬用錠剤コーティング技術の進歩が有利な成長機会をもたらす

フィルムコーティング作業のデータ収集とリアルタイムモニタリングに向けた新しいプロセス分析技術（PAT）ツールの導入は、世界の製薬用錠剤コーティング市場の新たな動向です。さまざまなPATツールには、フィルムコーティング作業をモニターするための顕微鏡技術、分光技術、画像技術などの幅広い技術が含まれます。近年、さまざまな先進技術の開発に成功したことで、コーティング作業の拡張性が向上しました。例えば、ラマン分光技術は、より使いやすく、よりコンパクトな形状を実現し、キャリブレーションの安定性を高めるためにさまざまな改良が加えられました。同様に、ラトガース大学の研究グループは、先進のマルチポイントNIR空間分解分光（SRS）プローブを総合的に評価しました。これらのプローブは迅速で正確な測定を可能にします。この技術が提供する高い効率と精度により、1時間当たり約20万錠の検査が可能になっています。このような開発と進歩が、予測期間に市場に有利な成長機会をもたらす見込みです。

当レポートでは、世界の製薬用錠剤コーティング市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

• 市場の認知度と製品情報
• ブランド認知度とロイヤルティ
• 購入決定において考慮される要素
• 購入頻度
• 購入媒体

第5章 世界の製薬用錠剤コーティング市場の見通し（2017年～2031年）

• 市場規模と予測
  • 金額
  • 数量
• タイプ別
  • シュガーコーティング
  • フィルムコーティング
  • 腸溶性コーティング
  • ゼラチンコーティング
  • その他
• ポリマータイプ別
  • セルロース
  • ビニル
  • アクリル
  • その他
• 機能性別
  • 遅延放出
  • 徐放
• エンドユーザー別
  • 製薬
  • 栄養補助食品
• 地域別
  • 北米
  • 南米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
• 市場シェア：企業別（2023年）

第6章 世界の製薬用錠剤コーティング市場の見通し：地域別（2017年～2031年）

• 北米
  • 市場規模と予測
  • タイプ別
  • ポリマータイプ別
  • 機能性別
  • エンドユーザー別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 南米
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第7章 供給サイド分析

• 生産能力：企業別
• 生産：企業別
• 運転効率：企業別
• 主なプラントの所在地（最大25ヶ所）

第8章 市場マッピング（2023年）

• タイプ別
• ポリマータイプ別
• 機能性別
• エンドユーザー別
• 地域別

第9章 マクロ環境と産業構造

• 需給分析
• 輸入輸出分析
• サプライチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第10章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第11章 主要企業の情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益分析（2023年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場企業5社）
• 特許分析（該当する場合）

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

• NEHA LIFE SCIENCES PVT. LTD.
• UPM Pharmaceuticals, Inc.
• Evonik Industries
• BASF Pharma
• Colorcon
• EasyCoat
• METTLER TOLEDO
• Lonza
• Qualicaps
• SPI Pharma

第15章 戦略的推奨

第16章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1.Global Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 2.Global Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 3.Global Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 4.Global Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 5.Global Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 6.Global Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 7.Global Pharma Tablet Coatings Market Share (%), By Region, 2017-2031F
• Figure 8.North America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 9.North America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 10.North America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 11.North America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 12.North America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 13.North America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 14.North America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
• Figure 15.United States Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 16.United States Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 17.United States Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 18.United States Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 19.United States Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 20.United States Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 21.Canada Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 22.Canada Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 23.Canada Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 24.Canada Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 25.Canada Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 26.Canada Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 27.Mexico Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 28.Mexico Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 29.Mexico Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 30.Mexico Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 31.Mexico Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 32.Mexico Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 33.Europe Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 34.Europe Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 35.Europe Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 36.Europe Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 37.Europe Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 38.Europe Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 39.Europe Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
• Figure 40.Germany Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 41.Germany Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 42.Germany Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 43.Germany Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 44.Germany Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 45.Germany Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 46.France Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 47.France Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 48.France Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 49.France Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 50.France Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 51.France Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 52.Italy Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 53.Italy Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 54.Italy Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 55.Italy Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 56.Italy Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 57.Italy Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 58.United Kingdom Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 59.United Kingdom Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 60.United Kingdom Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 61.United Kingdom Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 62.United Kingdom Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 63.United Kingdom Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 64.Russia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 65.Russia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 66.Russia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 67.Russia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 68.Russia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 69.Russia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 70.Netherlands Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 71.Netherlands Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 72.Netherlands Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 73.Netherlands Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 74.Netherlands Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 75.Netherlands Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 76.Spain Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 77.Spain Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 78.Spain Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 79.Spain Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 80.Spain Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 81.Spain Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 82.Turkey Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 83.Turkey Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 84.Turkey Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 85.Turkey Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 86.Turkey Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 87.Turkey Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 88.Poland Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 89.Poland Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 90.Poland Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 91.Poland Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 92.Poland Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 93.Poland Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 94.South America Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 95.South America Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 96.South America Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 97.South America Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 98.South America Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 99.South America Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 100.South America Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
• Figure 101.Brazil Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 102.Brazil Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 103.Brazil Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 104.Brazil Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 105.Brazil Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 106.Brazil Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 107.Argentina Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 108.Argentina Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 109.Argentina Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 110.Argentina Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 111.Argentina Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 112.Argentina Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 113.Asia-Pacific Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 114.Asia-Pacific Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 115.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 116.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 117.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 118.Asia-Pacific Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 119.Asia-Pacific Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
• Figure 120.India Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 121.India Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 122.India Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 123.India Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 124.India Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 125.India Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 126.China Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 127.China Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 128.China Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 129.China Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 130.China Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 131.China Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 132.Japan Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 133.Japan Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 134.Japan Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 135.Japan Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 136.Japan Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 137.Japan Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 138.Australia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 139.Australia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 140.Australia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 141.Australia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 142.Australia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 143.Australia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 144.Vietnam Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 145.Vietnam Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 146.Vietnam Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 147.Vietnam Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 148.Vietnam Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 149.Vietnam Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 150.South Korea Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 151.South Korea Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 152.South Korea Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 153.South Korea Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 154.South Korea Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 155.South Korea Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 156.Indonesia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 157.Indonesia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 158.Indonesia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 159.Indonesia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 160.Indonesia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 161.Indonesia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 162.Philippines Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 163.Philippines Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 164.Philippines Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 165.Philippines Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 166.Philippines Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 167.Philippines Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 168.Middle East & Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 169.Middle East & Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 170.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 171.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 172.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 173.Middle East & Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 174.Middle East & Africa Pharma Tablet Coatings Market Share (%), By Country, 2017-2031F
• Figure 175.Saudi Arabia Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 176.Saudi Arabia Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 177.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 178.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 179.Saudi Arabia Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 180.Saudi Arabia Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 181.UAE Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 182.UAE Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 183.UAE Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 184.UAE Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 185.UAE Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 186.UAE Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 187.South Africa Pharma Tablet Coatings Market, By Value, In USD Billion, 2017-2031F
• Figure 188.South Africa Pharma Tablet Coatings Market, By Volume, In Kilotons, 2017-2031F
• Figure 189.South Africa Pharma Tablet Coatings Market Share (%), By Type, 2017-2031F
• Figure 190.South Africa Pharma Tablet Coatings Market Share (%), By Polymer Type, 2017-2031F
• Figure 191.South Africa Pharma Tablet Coatings Market Share (%), By Functionality, 2017-2031F
• Figure 192.South Africa Pharma Tablet Coatings Market Share (%), By End-user, 2017-2031F
• Figure 193.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194.By Polymer Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195.By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global pharma tablet coatings market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 1.01 billion in 2023 to USD 1.62 billion in 2031F. The growth of the market is supported by the expansion in the pharmaceutical sector and increasing research and development activities.

The rapid growth of the pharmaceutical sector is boosting the global pharma tablet coatings market size. The growth can be attributed to the increasing prevalence of various diseases and disorders and exponential rise in population in various regions across the globe. For instance, Invest India estimated that the pharmaceutical industry in the country is expected to reach USD 130 billion by 2030. Moreover, the increasing emphasis on the quality of pharmaceutical products manufacturing and rising adoption of generic drugs provide lucrative growth opportunities to the market, boosting the requirement for pharma tablet coatings. The increase in stringency by regulatory bodies regarding different excipients and drugs further bolstered the market expansion.

The rising investments by key players in the market to produce equipment that supports the delivery of viable pharma tablet coatings cost-efficient and timely are further propelling the global pharma tablet coatings market growth. Additionally, the rising popularity of biosimilars owing to their cost-effective nature, which increases the accessibility to various treatments and improves the quality of life of the patients, is supporting the expansion of the market for tablet coatings. For instance, 2022 Biosimilar Trends Report by Amgen Biosimilars estimates that for the biosimilars launched in the past three years, in the therapeutic areas, average share was 75%. Biosimilars mimic the active ingredient in the reference biologic and undergo extensive analysis to confirm the presence of similar characteristics to that of the reference biologics. Thus, the biosimilars sector is witnessing significant growth, which in turn is boosting the requirement for pharma tablet coatings and positively influencing the expansion of the market.

Increasing Adoption of Generics Boost Global Pharma Tablet Coatings Market Demand

The growing popularity of generics can be attributed to their cost-effective nature and the rising awareness of strict regulatory standards these drugs must follow. To receive the stamp of approval from the FDA, the generic drugs must be bioequivalent to their brand-name counterpart. It ensures that two drugs are chemically the same, though the makers of the generic medication are allowed a variation of twenty percent in the active ingredient from the original formula. Even though the wiggle room allowed by the FDA is up to 20%, variations of less than 4% are usually observed. Due to the increasing awareness among the general population about such strict regulatory standards followed by generic medications has boosted confidence in such drugs. For instance, the Association for Accessible Medicines estimates that approximately 90% of the prescriptions dispensed in the United States are of generics. Thus boosting the demand for pharma-coating tablets and supporting the market's growth.

Technological Advancements in Pharma Tablet Coatings Provide Lucrative Growth Opportunities

Introducing new process analytical technology (PAT) tools for data acquisition and real-time monitoring for filming coating operations is an emerging global pharma tablet coatings market trend. Various PAT tools include a wide range of techniques, such as microscopic techniques, spectroscopic techniques, and imaging techniques, to monitor the film coating operations. Recently, the successful development of various advanced technologies has aided in enhancing the scalability of the coating operations. For instance, the Raman spectroscopy technology underwent various improvements to make it more user-friendly, achieving a more compact form factor, and enhance the calibration stability. Similarly, a research group at Rutgers University comprehensively evaluated advanced multi-point NIR spatially resolved spectroscopy (SRS) probes. These probes provide rapid and precise measurements. The high efficiency and precision offered by this technology has allowed the inspection of approximately 200,000 tablets per hour. Such developments and advancements will provide lucrative growth opportunities to the market over the forecast period.

North America Accounts for a Significant Share of the Market

The growth of North America pharma tablet coatings market can be attributed to the rapid expansion of pharmaceutical sector in the region, strong presence of various leading market players, and increasing prevalence of several diseases and disorders. The rising investments by the market players based in the region towards the development of novel products and technologies are further aiding the growth of the market in North America.

For instance, in May 2023, Colorcon, headquartered in Pennsylvania, United States, introduced titanium dioxide-free film coating designed to mitigate the challenges associated with moisture-sensitive actives. Colorcon launched an Opadry film coating system that meets the moisture management requirements of pharmaceutical tablets without utilizing titanium dioxide. Through their portfolio of Opadry complete film coating systems, the company provides scope for reducing time-to-market and complexity by providing high-quality products to their customers. They are focused on carefully selecting ingredients that meet the local pharmaceutical regulatory requirements. Such regional developments will provide lucrative growth opportunities for the North American market.

Sustained Release Holds Significant Share of the Market

The growth of the segment can be attributed to the increasing prevalence of various diseases and disorders that require sustained and controlled release of drugs, including hypertension, diabetes, and asthma. For instance, the International Diabetes Federation estimated that, in 2021, approximately 10.5% of the adult population, i.e., individuals between the age of 20-79 years had diabetes. Also, by 2045 the number of cases of diabetes will witness an increase of 46% and 1 in 8 adults, about 783 million individuals will be living with diabetes. The increase in prevalence of diabetes will boost the requirement for sustained release pharma tablet costings, augmenting the market's growth.

Additionally, the utilization of sustained-release tablets offers various advantages, including slow drug release in the bloodstream, which allows for maintaining a constant level of medication in the bloodstream and removes the likelihood of burst drug release. Thus, it boosts demand and propels the market expansion.

Pharmaceutical Sector Accounts for Significant Market Share

The expansion of the pharmaceutical sector can be attributed to the exponential growth of the geriatric population, the increase in the prevalence of several diseases, and rising healthcare expenditure in various countries across the globe. Due to the growth, the requirement for pharma tablet coatings is increasing, augmenting the market demand. Additionally, the demand for tablet coatings by the pharmaceutical sector is augmenting as the prevalence of diseases that require tablet formulations as the primary form of treatment rises.

For instance, the rise in the number of cases of arthritis is boosting the demand for global pharma tablet coatings. According to the estimates of the Centers for Disease Control and Prevention, an estimated 53.2 million adults in the United States, approximately 21.2% of the population, have been diagnosed by a doctor to have some form of arthritis in 2023. The increase in the number of cases of arthritis is providing lucrative growth opportunities to the market as various corticosteroid medications are consumed as pills for slowing the joint damage and reducing pain and inflammation. Thus, boosting the requirement for pharma tablet coatings and supporting the expansion of the market.

Future Market Scenario (2024 - 2031F)

According to global pharma tablet coatings market analysis, the increasing emphasis on nanocoating technology will support the expansion of the market in the coming years. The growing utilization of nanotechnology will aid in enhancing the capabilities of the excipients. Nanocoating will aid in improving drug release profiles by enhancing the bioavailability of active pharmaceutical ingredient and controlling the release rate. Furthermore, the utilization of nanocoating technology will support the incorporation of different functional materials including antimicrobial agents, flavoring agents, antioxidants, and polymers, onto the surface of the tablet. The increasing utilization of nanocoating technology will provide various benefits and support the expansion of the market for pharma tablet coatings over the forecast period.

Key Players Landscape and Outlook

The increasing investments by the leading pharma tablet coatings market players towards the development of new coating manufacturing facilities will support the global pharma tablet coatings market growth. For instance, Colorcon is investing in the development of a new manufacturing facility in Johor State, Malaysia, through their subsidiary, Colorcon Malaysia. The facility will be producing advanced and high-quality film-coating products to cater to the requirements of nutraceutical and pharmaceutical manufacturers across the region of the Southeast Asia, comprising of New Zealand and Australia. With an investment of approximately USD 50 million, the strategic approach of Colorcon to be located closer to their customers will boost the ability of the company to cater to the expected growth in the region. Thus, increase in such investments over the forecast period will provide lucrative growth opportunities for the market.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

• 4.1.Market Awareness and Product Information
• 4.2.Brand Awareness and Loyalty
• 4.3.Factors Considered in Purchase Decision
  • 4.3.1.Brand Name
  • 4.3.2.Quality
  • 4.3.3.Quantity
  • 4.3.4.Price
  • 4.3.5.Product Specification
  • 4.3.6.Form Specification
  • 4.3.7.Shelf Life
  • 4.3.8.Availability of Product
• 4.4.Frequency of Purchase
• 4.5.Medium of Purchase

5.Global Pharma Tablet Coatings Market Outlook, 2017-2031F

• 5.1.Market Size & Forecast
  • 5.1.1.By Value
  • 5.1.2.By Volume
• 5.2.By Type
  • 5.2.1.Sugar Coated
  • 5.2.2.Film Coated
  • 5.2.3.Enteric Coated
  • 5.2.4.Gelatin Coated
  • 5.2.5.Others
• 5.3.By Polymer Type
  • 5.3.1.Cellulosic
  • 5.3.2.Vinyl
  • 5.3.3.Acrylic
  • 5.3.4.Others
• 5.4.By Functionality
  • 5.4.1.Delayed-Release
  • 5.4.2.Sustained-Release
• 5.5.By End-user
  • 5.5.1.Pharmaceutical
  • 5.5.2.Nutraceutical
• 5.6.By Region
  • 5.6.1.North America
  • 5.6.2.South America
  • 5.6.3.Europe
  • 5.6.4.Asia-Pacific
  • 5.6.5.Middle East and Africa
• 5.7.By Company Market Share (%), 2023

6.Global Pharma Tablet Coatings Market Outlook, By Region, 2017-2031F

• 6.1.North America*
  • 6.1.1.Market Size & Forecast
    • 6.1.1.1.By Value
    • 6.1.1.2.By Volume
  • 6.1.2.By Type
    • 6.1.2.1.Sugar Coated
    • 6.1.2.2.Film Coated
    • 6.1.2.3.Enteric Coated
    • 6.1.2.4.Gelatin Coated
    • 6.1.2.5.Others
  • 6.1.3.By Polymer Type
    • 6.1.3.1.Cellulosic
    • 6.1.3.2.Vinyl
    • 6.1.3.3.Acrylic
    • 6.1.3.4.Others
  • 6.1.4.By Functionality
    • 6.1.4.1.Delayed-Release
    • 6.1.4.2.Sustained-Release
  • 6.1.5.By End-user
    • 6.1.5.1.Pharmaceutical
    • 6.1.5.2.Nutraceutical
  • 6.1.6.United States*
    • 6.1.6.1.Market Size & Forecast
      • 6.1.6.1.1.By Value
      • 6.1.6.1.2.By Volume
    • 6.1.6.2.By Type
      • 6.1.6.2.1.Sugar Coated
      • 6.1.6.2.2.Film Coated
      • 6.1.6.2.3.Enteric Coated
      • 6.1.6.2.4.Gelatin Coated
      • 6.1.6.2.5.Others
    • 6.1.6.3.By Polymer Type
      • 6.1.6.3.1.Cellulosic
      • 6.1.6.3.2.Vinyl
      • 6.1.6.3.3.Acrylic
      • 6.1.6.3.4.Others
    • 6.1.6.4.By Functionality
      • 6.1.6.4.1.Delayed-Release
      • 6.1.6.4.2.Sustained-Release
    • 6.1.6.5.By End-user
      • 6.1.6.5.1.Pharmaceutical
      • 6.1.6.5.2.Nutraceutical
  • 6.1.7.Canada
  • 6.1.8.Mexico

All segments will be provided for all regions and countries covered

• 6.2.Europe
  • 6.2.1.Germany
  • 6.2.2.France
  • 6.2.3.Italy
  • 6.2.4.United Kingdom
  • 6.2.5.Russia
  • 6.2.6.Netherlands
  • 6.2.7.Spain
  • 6.2.8.Turkey
  • 6.2.9.Poland
• 6.3.Asia-Pacific
  • 6.3.1.India
  • 6.3.2.China
  • 6.3.3.Japan
  • 6.3.4.Australia
  • 6.3.5.Vietnam
  • 6.3.6.South Korea
  • 6.3.7.Indonesia
  • 6.3.8.Philippines
• 6.4.South America
  • 6.4.1.Brazil
  • 6.4.2.Argentina
• 6.5.Middle East and Africa
  • 6.5.1.Saudi Arabia
  • 6.5.2.UAE
  • 6.5.3.South Africa

7.Supply Side Analysis

• 7.1.Capacity, By Company
• 7.2.Production, By Company
• 7.3.Operating Efficiency, By Company
• 7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

• 8.1.By Type
• 8.2.By Polymer Type
• 8.3.By Functionality
• 8.4.By End-user
• 8.5.By Region

9.Macro Environment and Industry Structure

• 9.1.Supply Demand Analysis
• 9.2.Import Export Analysis
• 9.3.Supply Chain Analysis
• 9.4.PESTEL Analysis
  • 9.4.1.Political Factors
  • 9.4.2.Economic System
  • 9.4.3.Social Implications
  • 9.4.4.Technological Advancements
  • 9.4.5.Environmental Impacts
  • 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 9.5.Porter's Five Forces Analysis
  • 9.5.1.Supplier Power
  • 9.5.2.Buyer Power
  • 9.5.3.Substitution Threat
  • 9.5.4.Threat from New Entrant
  • 9.5.5.Competitive Rivalry

10.Market Dynamics

• 10.1.Growth Drivers
• 10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

• 11.1.Competition Matrix of Top Five Market Leaders
• 11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
• 11.4.SWOT Analysis (For Five Market Players)
• 11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

• 14.1.NEHA LIFE SCIENCES PVT. LTD.
  • 14.1.1.Company Details
  • 14.1.2.Key Management Personnel
  • 14.1.3.Products & Services
  • 14.1.4.Financials (As reported)
  • 14.1.5.Key Market Focus & Geographical Presence
  • 14.1.6.Recent Developments
• 14.2.UPM Pharmaceuticals, Inc.
• 14.3.Evonik Industries
• 14.4.BASF Pharma
• 14.5.Colorcon
• 14.6.EasyCoat
• 14.7.METTLER TOLEDO
• 14.8.Lonza
• 14.9.Qualicaps
• 14.10.SPI Pharma

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.Strategic Recommendations

16.About Us & Disclaimer